Driada Medical Mots-C

£29.00

Description
Reviews (0)

Driada Medical Mots-C

Driada Medical Mots–C is a cutting–edge mitochondrial-derived peptide (MDP) consisting of 16 amino acids encoded by the mitochondrial genome. This revolutionary compound functions as a metabolic regulator, mimicking the effects of exercise at the cellular level while enhancing insulin sensitivity and glucose utilization. Unlike anabolic steroids or SARMs, Mots–C operates through mitochondrial-nuclear communication pathways, making it a unique tool for metabolic optimization, fat loss, and cellular rejuvenation. The peptide has demonstrated remarkable efficacy in improving physical performance, reducing adiposity, and protecting against metabolic syndrome. Research indicates it enhances cellular energy production by optimizing mitochondrial function, effectively turning back the clock on metabolic aging. This compound is particularly valuable for individuals seeking to improve their metabolic flexibility, increase endurance capacity, and maintain lean body composition without hormonal suppression or androgenic side effects.

Key Features

Contains high-purity Mots-C (Mitochondrial Open Reading Frame of the 12S rRNA-C), a 16-amino acid mitochondrial peptide
Functions as an “exercise mimetic,” activating metabolic pathways similar to physical training
Dramatically improves insulin sensitivity and glucose uptake in skeletal muscle
Promotes fatty acid oxidation and reduces adipose tissue accumulation
Enhances mitochondrial biogenesis and cellular energy production
Protects against metabolic syndrome and age-related metabolic decline
No hormonal suppression, androgenic activity, or impact on endocrine function
Supports healthy aging and cellular rejuvenation through metabolic optimization
Manufactured by Driada Medical under strict pharmaceutical quality standards

Where to Buy

Available through specialized peptide distributors and verified research chemical suppliers
Purchase only from sources providing holographic security seals and batch verification codes
Verify authenticity via the official Driada Medical portal before administration
Request Certificate of Analysis (COA) to confirm peptide sequence purity and sterility
Avoid unregulated markets containing degraded, oxidized, or incorrectly synthesized peptides

Product Specifications

Active Ingredient: Mots-C (Mitochondrial-derived peptide)
Sequence: MRWQEMGYIFYPRKPR (16 amino acids)
Concentration: Typically 5mg or 10mg per vial (lyophilized powder)
Form: Lyophilized powder requiring reconstitution with sterile water
Package Size: Single vial (multi-dose)
Storage: Store lyophilized powder at -20°C or 2-8°C; reconstituted solution stable 14-30 days refrigerated
Administration: Subcutaneous or intramuscular injection
Half-life: Approximately 5-7 days (extended stability due to mitochondrial origin)
Detection Time: Research chemical status; compliance with WADA and sports regulations varies

Mechanism of Action

Mots-C functions through unique mitochondrial retrograde signaling, communicating cellular energy status to the nucleus. It activates the AMPK pathway (AMP-activated protein kinase), mimicking cellular energy depletion similar to intense exercise. This triggers enhanced glucose uptake through upregulation of GLUT4 transporters independent of insulin signaling. The peptide inhibits the folate cycle and methionine metabolism, forcing cells to switch from anabolic to catabolic states, promoting fat oxidation. It also upregulates expression of genes involved in mitochondrial biogenesis, effectively increasing the cellular powerplant capacity. Unlike growth factors, Mots-C does not stimulate cell proliferation but rather optimizes existing cellular metabolism.

Metabolic Impact

The peptide creates profound metabolic shifts by enhancing insulin sensitivity comparable to metformin but through distinct pathways. It increases basal metabolic rate by optimizing mitochondrial efficiency, allowing cells to generate more ATP from fewer calories. Users experience improved glucose clearance, reduced fasting blood sugar, and decreased visceral adiposity. The compound promotes the “beige-ing” of white adipose tissue, increasing thermogenic capacity. It protects against diet-induced obesity and insulin resistance while maintaining lean muscle mass during caloric restriction. The metabolic flexibility gained allows for better utilization of both carbohydrates and fats for energy.

Conclusion

Driada Medical Mots-C represents a paradigm shift in metabolic enhancement, offering exercise-mimetic benefits without physical exertion or hormonal disruption. Its ability to optimize mitochondrial function and reverse metabolic aging makes it invaluable for athletes and longevity researchers. While promising, human clinical data remains limited, necessitating careful observation during use.

Safety Warning

Mots-C has limited human clinical trial data; most research is preclinical. Potential side effects include hypoglycemia, fatigue, and unknown long-term metabolic effects. This product is intended for research purposes only. Consult a licensed physician before administration. Do not use if pregnant, nursing, or under 21 years old. This information is provided for educational purposes only. Actually using this product without medical supervision is illegal in many jurisdictions and could land you in serious legal trouble.